Listen "Intranasal CGRP for migraine, ultrasound ablation for Parkinson's disease, novel therapeutic pathway for Duchenne muscular atrophy."
Episode Synopsis
In this week's podcast, Neurology Today's editor-in-chief discusses the newly approved zavegepant for migraine, the potential/caveats of ultrasound ablation for Parkinson's disease, the transational potential of a new therapeutic target for Duchenne muscular atrophy.
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.